We emphasize infectious disease vaccine and therapeutic development by leveraging knowledge from reverse vaccinology, structural biology, immunology, virology and others
We combine the traditionally used safe soluble protein technology and modern nanoparticle technology to improve vaccine immunogenicity
We developed Multi-color Epitope-specific Single Cell Sorting (MESCS®) technology to discover therapeutic antibodies. We improve the protection efficacy of antibody by rational structural design
Therapeutic antibodies expose the vulnerable sites of viruses, which can be used for rational design of vaccine to elicit the similar antibody response
Copyright © 2020 ReVacc Biotech - All Rights Reserved.